The progression potential of peritoneal dissemination nodules from gastrointestinal tumors

International Surgery

Volumn 96, Issue 4, 2011, Pages 352-357

  Yamauchi, Hayato ^a   Suto, Toshinaga ^a   Kigure, Wakako ^a   Morita, Hiroki ^a   Kato, Toshihide ^a   Yajima, Reina ^a   Fujii, Takaaki ^a   Yamaguchi, Satoru ^a   Tsutsumi, Soichi ^a   Asao, Takayuki ^a   Kuwano, Hiroyuki ^a  

^a GUNMA UNIVERSITY   (Japan)

Author keywords

Gastrointestinal cancer; Ki 67; Peritoneal dissemination

Indexed keywords

KI 67 ANTIGEN;

AGED; ARTICLE; COLON TUMOR; DISEASE COURSE; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY; PERITONEUM; STOMACH TUMOR;

AGED; COLONIC NEOPLASMS; DISEASE PROGRESSION; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; MALE; MIDDLE AGED; PERITONEUM; STOMACH NEOPLASMS;

EID: 84864560477     PISSN: 00208868     EISSN: None     Source Type: Journal    
DOI: 10.9738/CC21.1     Document Type: Article

References (31)

1. Baba H, Korenaga D, Okamura T, Saito A, Sugimachi K. Prognostic factors in gastric cancer with serosal invasion. Univariate and multivariate analyses. Arch Surg 1989;124(9): 1061-1064
2. Chu DZ, Lang NP, Thompson C, Osteen PK, Westbrook KC. Peritoneal carcinomatosis in nongynecologic malignancy. A prospective study of prognostic factors. Cancer 1989;63(2):364-367
3. Jayne DG, Fook S, Loi C, Seow-Choen F. Peritoneal carcinomatosis from colorectal cancer. Br J Surg 2002;89(12):1545-1550
4. Kodera Y, Yamamura Y, Torii A, Uesaka K, Hirai T, Yasui K. Postoperative staging of gastric carcinoma. A comparison between the UICC stage classification and the 12th edition of the Japanese General Rules for Gastric Cancer Study. Scand J Gastroenterol 1996;31(5):476-480
5. Rampone B, Schiavone B, Martino A, Confuorto G. Current role of hyperthermic intraperitoneal chemotherapy in the treatment of peritoneal carcinomatosis from colorectal cancer. World J Gastroenterol 2010;16(11):1299-1302
6. Shah MA, Schwartz GK. Cell cycle-mediated drug resistance: an emerging concept in cancer therapy. Clin Cancer Res 2001;7(8):2168-2181
7. Chang J, Powles TJ, Allred DC, Ashley SE, Clark GM, Makris A. Biologic markers as predictors of clinical outcome from systemic therapy for primary operable breast cancer. J Clin Oncol 1999;17(10):3058-3063
8. Gonzalez-Vela MC, Garijo MF, Fernandez F, Val-Bernal JF. MIB1 proliferation index in breast infiltrating carcinoma: comparison with other proliferative markers and association with new biological prognostic factors. Histol Histopathol 2001;16(2):399-406
9. MacGrogan G, Mauriac L, Durand M, Bonichon F, Trojani M, de Mascarel I. Primary chemotherapy in breast invasive carcinoma: predictive value of the immunohistochemical detection of hormonal receptors, p53, c-erbB-2, MiB1, pS2 and GST pi. Br J Cancer 1996;74(9):1458-1465
10. Saito A, Korenaga D, Maehara Y, Baba H, Okamura T, Sugimachi K. In vitro succinate dehydrogenase chemosensitivity of gastric carcinoma - relationship to DNA content. Cancer Chemother Pharmacol 1992;29(3):185-189
11. Sjostrom J, Blomqvist C, Heikkila P, Boguslawski KV, Raisanen-Sokolowski A, Bengtsson NO. Predictive value of p53, mdm-2, p21, and mib-1 for chemotherapy response in advanced breast cancer. Clin Cancer Res 2000;6(8):3103- 3110
12. Brown DC, Gatter KC. Ki67 protein: the immaculate deception? Histopathology 2002;40(1):2-11
13. Scholzen T, Gerdes J. The Ki-67 protein: from the known and the unknown. J Cell Physiol 2000;182(3):311-322
14. Sampson JA. Implantation peritoneal carcinomatosis of ovarian origin. Am J Pathol 1931;7(5):423-444
15. Iitsuka Y, Kaneshima S, Tanida O, Takeuchi T, Koga S. Intraperitoneal free cancer cells and their viability in gastric cancer. Cancer 1979;44(4):1476-1480
16. Jayne D. Molecular biology of peritoneal carcinomatosis. Cancer Treat Res 2007;134:21-33
17. Bando E, Yonemura Y, Takeshita Y, Taniguchi K, Yasui T, Yoshimitsu Y. Intraoperative lavage for cytological examination in 1,297 patients with gastric carcinoma. Am J Surg 1999;178(3):256-262
18. Boku T, Nakane Y, Minoura T, Takada H, Yamamura M, Hioki K. Prognostic significance of serosal invasion and free intraperitoneal cancer cells in gastric cancer. Br J Surg 1990;77(4):436-439
19. Okajima K, Yamada S. Surgical treatment of far-advanced gastric cancer [in Japanese]. Gan No Rinsho 1986;32(10):1203- 1209
20. Bonenkamp JJ, Sasako M, Hermans J, van de Velde CJ. Tumor load and surgical palliation in gastric cancer. Hepatogastroenterology 2001;48(41):1219-1221
21. Gretschel S, Siegel R, Estevez-Schwarz L, Hunerbein M, Schneider U, Schlag PM. Surgical strategies for gastric cancer with synchronous peritoneal carcinomatosis. Br J Surg 2006;93(12):1530-1535
22. Sugarbaker PH, Yonemura Y. Clinical pathway for the management of resectable gastric cancer with peritoneal seeding: best palliation with a ray of hope for cure. Oncology 2000;58(2):96-107
23. Richter A, Niedergethmann M, Sturm JW, Lorenz D, Post S, Trede M. Long-term results of partial pancreaticoduodenectomy for ductal adenocarcinoma of the pancreatic head: 25- year experience. World J Surg 2003;27(3):324-329
24. Kayahara M, Nagakawa T, Ueno K, Ohta T, Takeda T, Miyazaki I. An evaluation of radical resection for pancreatic cancer based on the mode of recurrence as determined by autopsy and diagnostic imaging. Cancer 1993;72(7):2118-2123
25. Nitecki SS, Sarr MG, Colby TV, van Heerden JA. Long-term survival after resection for ductal adenocarcinoma of the pancreas. Is it really improving? Ann Surg 1995;221(1):59-66
26. Sperti C, Pasquali C, Piccoli A, Pedrazzoli S. Recurrence after resection for ductal adenocarcinoma of the pancreas. World J Surg 1997;21(2):195-200
27. Takahashi S, Ogata Y, Miyazaki H, Maeda D, Murai S, Yamataka K. Aggressive surgery for pancreatic duct cell cancer: feasibility, validity, limitations. World J Surg 1995;19(4):653-660
28. Little JB, Nagasawa H, Pfenning T, Vetrovs H. Radiationinduced genomic instability: delayed mutagenic and cytogenetic effects of X rays and alpha particles. Radiat Res 1997;148(4):299-307
29. Marder BA, Morgan WF. Delayed chromosomal instability induced by DNA damage. Mol Cell Biol 1993;13(11):6667-6677
30. Sasaki MS. Delayed manifestation and transmission bias of de novo chromosome mutations: their relevance for radiation health effect. J Radiat Res (Tokyo) 2006;47(suppl B):B45-56
31. Seymour C, Mothersill C. All colonies of CHO-K1 cells surviving gamma-irradiation contain non-viable cells. Mutat Res 1992;267(1):19-30